title: Mucosal glutamine utilization after small-bowel transplantation: an electrophysiologic study.
abstract: A short course of FK 506 after small bowel transplantation averts rejection in the rat and achieves indefinite survival of the recipient whose nutritional status is dependent on the function of the intestinal graft. Ex vivo electrophysiologic studies using the Ussing Cell were conducted to delineate functional competence of the graft by evaluating mucosal ion transport and glutamine utilization. Orthotopic small-bowel transplantation was performed in Lewis (LEW) rats as recipients of either Brown-Norway (BN) allografts or LEW syngeneic grafts. Allograft recipients received FK 506 either as a short course (2 mg/kg on Day 0-4 after transplantation) or continuously (2 mg/kg Day 0-4, then 0.5 mg/kg weekly). Ileal mucosa was harvested from small bowel grafts 9 and 60 days after transplantation and mounted in the Ussing Cell containing Hanks' balanced salt solution with/without L-glutamine (20 mM). Transmembrane potential difference (PD), which represents mucosal active ion transport, and mucosal resistance, an index of membrane integrity, were recorded. Nine days after transplantation, mucosal PD was the same in the ileum from syngeneic grafts, allografts treated with FK 506 and normal LEW and BN rats, and the addition of glutamine increased PD equally in all groups. In comparison, PD was markedly decreased in allografts undergoing rejection, and the glutamine response was blunted. Sixty days after transplantation, mucosal PD was reduced in allografts treated with a short course of FK 506, but normal in allografts receiving continuous immunosuppression with FK 506 and in syngeneic grafts. A decrease of mucosal resistance was not a feature of rejection nor a sequel of limited FK 506 therapy. Our data indicate that allograft rejection results in a significant decrease in mucosal PD and a poor response to glutamine. Control of rejection by FK 506 preserves normal electrophysiologic responses of the allograft mucosa.
authors.affiliation: Department of Surgery, University of Pittsburgh, Pennsylvania 15261.
authors.forename: T K
authors.initials: TK
authors.lastname: Lee
authors.forename: M A
authors.initials: MA
authors.lastname: Cardona
authors.forename: A G
authors.initials: AG
authors.lastname: Kurkchubasche
authors.forename: S D
authors.initials: SD
authors.lastname: Smith
authors.forename: A R
authors.initials: AR
authors.lastname: Mueller
authors.forename: K K
authors.initials: KK
authors.lastname: Lee
authors.forename: M I
authors.initials: MI
authors.lastname: Rowe
authors.forename: W H
authors.initials: WH
authors.lastname: Schraut
mesh_terms: D000818:Animals; D005973:Glutamine / Q000378:metabolism*; D007413:Intestinal Mucosa / Q000378:metabolism* / Q000473:pathology; D007421:Intestine, Small / Q000473:pathology / Q000502:physiology / Q000637:transplantation*; D008564:Membrane Potentials; D051381:Rats; D011914:Rats, Inbred BN; D011917:Rats, Inbred Lew; D016559:Tacrolimus / Q000494:pharmacology; D014184:Transplantation, Homologous
chemical_list: D005973:Glutamine; D016559:Tacrolimus